Phase II trial of preoperative radiation with Concurrent Capecitabine, Oxaliplatin, and Bevacizumab followed by surgery and postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: 5-year clinical outcomes Ecog-Acrin cancer research group E3204
Jerome C. Landry, Yang Feng, Roshan S. Prabhu, Steven J. Cohen, Charles A. Staley, Richard Whittington, Elin Ruth Sigurdson, Halla Nimeiri, Udit Verma, Al Bowen Benson
Research output: Contribution to journal › Article › peer-review
43Scopus
citations
Fingerprint
Dive into the research topics of 'Phase II trial of preoperative radiation with Concurrent Capecitabine, Oxaliplatin, and Bevacizumab followed by surgery and postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: 5-year clinical outcomes Ecog-Acrin cancer research group E3204'. Together they form a unique fingerprint.